格列齐特|真实世界中的研究：格列齐特缓释片和西格列汀在治疗2型糖尿病的疗效比较( 二 )
Khunti K, Godec TR, Medina J, et al. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapyafter metformin monotherapy: retrospective data for 10 256 individ-uals from the United Kingdom and Germany. Diabetes Obes Metab.2018;20(2):389-399.
Sharma M, Beckley N, Nazareth I, Petersen I. Effectiveness ofsitagliptin compared to sulfonylureas for type 2 diabetes mellitusinadequately controlled on metformin: a systematic review and meta-analysis. BMJ Open. 2017;7(10):e017260.
Rosenstock J, Kahn SE, Johansen OE, et al. Effect of Linagliptin vsglimepiride on major adverse cardiovascular outcomes in patientswith type 2 diabetes: the CAROLINA randomized clinical trial. JAMA.2019;322(12):1155-1166.
Khunti K, Chatterjee S, Gerstein HC, Zoungas S, Davies MJ. Do sulphonylureas still have a place in clinical practice? Lancet Diabetes Endocrinol. 2018;6(10):821-832.
Chan SP, Colagiuri S. Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents. Diabetes Res Clin Pract. 2015;110(1):75-81.
Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S. Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events. Diabetes Care. 2017;40(11):1506-1513.
推荐阅读
- 胰岛素|多吃饭多打胰岛素会有什么结果？一个真实案例告诉你
- 多吃饭多打胰岛素会有什么结果？一个真实的案例诉你
- 肛肠疾病|痛到喊妈！真实看病经历泣血奉上，必须保护好“菊花”
- 腋臭|真实故事：我的青春期是狐臭味的……
- 阿兹夫定|真实生物阿兹夫定片获批上市，憾失首个抗艾口服药“宝座”，市场却更广阔
- 达格列净|达格列净：把糖尿出去，降血糖保护心肾，了解3个注意事项很重要
- 肛肠疾病|痛到喊妈！真实看病经历泣血奉上，必须保护好菊花
- 真实世界研究|NEJM：科兴灭活疫苗的真实世界研究数据首次公布！
- 疫苗接种|德国建议混合疫苗接种方案 多项研究显示真实世界疫苗有效性
- 减肥|中年妈妈减肥图鉴，哈哈哈哈哈哈哈哈太真实了